Kelonia Therapeutics

Kelonia Therapeutics

Biotechnology, 750 Chase Pkwy, Boston, Massachusetts, 06708, United States, 11-50 Employees

keloniatx.com

  • LinkedIn

phone no Phone Number: +12*********

Who is KELONIA THERAPEUTICS

Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The companys simple and elegant cutting-edge in vivo gene delivery technology uses ...

Read More

map
  • 750 Chase Pkwy, Boston, Massachusetts, 06708, United States Headquarters: 750 Chase Pkwy, Boston, Massachusetts, 06708, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $500 Million to $1 Billion

industries-icon Industry: Biotechnology

SIC SIC Code: 8011 | NAICS Code: 621111 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from KELONIA THERAPEUTICS

Kelonia Therapeutics Org Chart and Mapping

Employees

Gabrielle Feig

Senior Associate Scientist

Tharani Sivanandam

Senior Associate Scientist

Urmi Patankar

Senior Associate Scientist

Maggie Lau

Senior Associate Scientist II - Analytical Development

Alex Najibi

Scientist, T Cell Biology

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Kelonia Therapeutics

Answer: Kelonia Therapeutics's headquarters are located at 750 Chase Pkwy, Boston, Massachusetts, 06708, United States

Answer: Kelonia Therapeutics's phone number is +12*********

Answer: Kelonia Therapeutics's official website is https://keloniatx.com

Answer: Kelonia Therapeutics's revenue is $500 Million to $1 Billion

Answer: Kelonia Therapeutics's SIC: 8011

Answer: Kelonia Therapeutics's NAICS: 621111

Answer: Kelonia Therapeutics has 11-50 employees

Answer: Kelonia Therapeutics is in Biotechnology

Answer: Kelonia Therapeutics contact info: Phone number: +12********* Website: https://keloniatx.com

Answer: Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The companys simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal of bringing genetic medicines to every patient in need.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access